Riley Brigit 4
4 · Adverum Biotechnologies, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-03-15$0.78/sh−7,299$5,705→ 117,435 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Includes 6,000 shares purchased on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.